Neuraxial infusions

Phillip C. Phan, Madhuri Are, Allen W. Burton

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

BACKGROUND: Treatment of severe pain in the seriously ill patient, whether cancer-related or not, remains challenging. Although the use of basic medical management strategies is effective in most patients, some 10% to 20% or more cancer patients have pain, which is refractory to traditional pharmacotherapy. It has been suggested that a fourth, "interventional" step be added onto the three-step WHO analgesic ladder. Intraspinal analgesic infusions have been shown to be effective in the treatment of refractory cancer pain and in those patients with intolerable opioid-related side effects. A review of the basic pharmacology, patient selection, implant process, evidence of efficacy, and overview of complications is presented. CONCLUSIONS: There is sufficient consistent evidence (one RCT, numerous prospective and retrospective series) to support the use of intraspinal analgesia for refractory cancer pain.

Original languageEnglish (US)
Pages (from-to)152-160
Number of pages9
JournalTechniques in Regional Anesthesia and Pain Management
Volume9
Issue number3
DOIs
StatePublished - Jul 2005

Fingerprint

Intractable Pain
Analgesics
Pain
Analgesia
Patient Selection
Opioid Analgesics
Neoplasms
Pharmacology
Drug Therapy
Therapeutics
Cancer Pain

Keywords

  • Chronic pain
  • Implantable pain pump
  • Intrathecal analgesia
  • Intrathecal therapy
  • Opioids
  • Spinal analgesia

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Neuraxial infusions. / Phan, Phillip C.; Are, Madhuri; Burton, Allen W.

In: Techniques in Regional Anesthesia and Pain Management, Vol. 9, No. 3, 07.2005, p. 152-160.

Research output: Contribution to journalArticle

Phan, Phillip C. ; Are, Madhuri ; Burton, Allen W. / Neuraxial infusions. In: Techniques in Regional Anesthesia and Pain Management. 2005 ; Vol. 9, No. 3. pp. 152-160.
@article{a3e3afd6d5824afa9377ffca0a163fc6,
title = "Neuraxial infusions",
abstract = "BACKGROUND: Treatment of severe pain in the seriously ill patient, whether cancer-related or not, remains challenging. Although the use of basic medical management strategies is effective in most patients, some 10{\%} to 20{\%} or more cancer patients have pain, which is refractory to traditional pharmacotherapy. It has been suggested that a fourth, {"}interventional{"} step be added onto the three-step WHO analgesic ladder. Intraspinal analgesic infusions have been shown to be effective in the treatment of refractory cancer pain and in those patients with intolerable opioid-related side effects. A review of the basic pharmacology, patient selection, implant process, evidence of efficacy, and overview of complications is presented. CONCLUSIONS: There is sufficient consistent evidence (one RCT, numerous prospective and retrospective series) to support the use of intraspinal analgesia for refractory cancer pain.",
keywords = "Chronic pain, Implantable pain pump, Intrathecal analgesia, Intrathecal therapy, Opioids, Spinal analgesia",
author = "Phan, {Phillip C.} and Madhuri Are and Burton, {Allen W.}",
year = "2005",
month = "7",
doi = "10.1053/j.trap.2005.06.008",
language = "English (US)",
volume = "9",
pages = "152--160",
journal = "Techniques in Regional Anesthesia and Pain Management",
issn = "1084-208X",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Neuraxial infusions

AU - Phan, Phillip C.

AU - Are, Madhuri

AU - Burton, Allen W.

PY - 2005/7

Y1 - 2005/7

N2 - BACKGROUND: Treatment of severe pain in the seriously ill patient, whether cancer-related or not, remains challenging. Although the use of basic medical management strategies is effective in most patients, some 10% to 20% or more cancer patients have pain, which is refractory to traditional pharmacotherapy. It has been suggested that a fourth, "interventional" step be added onto the three-step WHO analgesic ladder. Intraspinal analgesic infusions have been shown to be effective in the treatment of refractory cancer pain and in those patients with intolerable opioid-related side effects. A review of the basic pharmacology, patient selection, implant process, evidence of efficacy, and overview of complications is presented. CONCLUSIONS: There is sufficient consistent evidence (one RCT, numerous prospective and retrospective series) to support the use of intraspinal analgesia for refractory cancer pain.

AB - BACKGROUND: Treatment of severe pain in the seriously ill patient, whether cancer-related or not, remains challenging. Although the use of basic medical management strategies is effective in most patients, some 10% to 20% or more cancer patients have pain, which is refractory to traditional pharmacotherapy. It has been suggested that a fourth, "interventional" step be added onto the three-step WHO analgesic ladder. Intraspinal analgesic infusions have been shown to be effective in the treatment of refractory cancer pain and in those patients with intolerable opioid-related side effects. A review of the basic pharmacology, patient selection, implant process, evidence of efficacy, and overview of complications is presented. CONCLUSIONS: There is sufficient consistent evidence (one RCT, numerous prospective and retrospective series) to support the use of intraspinal analgesia for refractory cancer pain.

KW - Chronic pain

KW - Implantable pain pump

KW - Intrathecal analgesia

KW - Intrathecal therapy

KW - Opioids

KW - Spinal analgesia

UR - http://www.scopus.com/inward/record.url?scp=25444504330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25444504330&partnerID=8YFLogxK

U2 - 10.1053/j.trap.2005.06.008

DO - 10.1053/j.trap.2005.06.008

M3 - Article

AN - SCOPUS:25444504330

VL - 9

SP - 152

EP - 160

JO - Techniques in Regional Anesthesia and Pain Management

JF - Techniques in Regional Anesthesia and Pain Management

SN - 1084-208X

IS - 3

ER -